Skip to main content
Equibles

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in AXGN — Axogen, Inc.

CIK 1164508 BOSTON, MA
Back to AXGN Full portfolio

Position in AXGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$20,463,324
+$11,872,815 QoQ
Shares Held
443,025
+70.9% QoQ
Ownership
0.824%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#33
of 253 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AXGN Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $6,436,102,900 across 46 Medical Devices names. AXGN ranks #18 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SYK
Stryker Corp
 3,282,207 $1,033,370,051
2 MDT
Medtronic plc
 12,892,710 $1,008,596,703
3 BSX
Boston Scientific Corp
 23,293,913 $994,184,206
4 ABT
Abbott Laboratories
 10,897,178 $988,809,931
5 EW
Edwards Lifesciences Corp
 5,677,344 $513,572,538
6 DXCM
Dexcom Inc
 6,873,273 $462,914,936
7 PEN
Penumbra Inc
 834,903 $263,620,622
8 STE
STERIS plc
 1,217,864 $256,445,622

All Filings in AXGN

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,463,324 443,025
2026-03-31 $8,590,509 259,297
2025-12-31 $23,230,804 709,771
2025-09-30 $8,720,709 488,829
2025-06-30 $315,973 29,122
2025-03-31 $1,799,865 97,290
2024-12-31 $1,603,339 97,290
2024-09-30 $995,307 70,992
2024-03-31 $141,402 17,522
2023-12-31 $362,625 53,093